A23L 33/13
Nucleic acids or derivatives thereof
Official title: Nucleic acids or derivatives thereof (A23L33/145 takes precedence)
A23L33/13 (Nucleic acids or derivatives thereof) appears on 145 US grants and 258 published applications in this corpus.
Search patents in A23L- Granted patents
- 145
- Published applications
- 258
- Assignees
- 142
- Inventors
- 546
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 0 |
| 2003 | 1 | 6 |
| 2004 | 1 | 4 |
| 2005 | 2 | 2 |
| 2006 | 2 | 5 |
| 2007 | 1 | 4 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 11 |
| 2011 | 4 | 6 |
| 2012 | 2 | 6 |
| 2013 | 4 | 8 |
| 2014 | 3 | 14 |
| 2015 | 6 | 15 |
| 2016 | 3 | 8 |
| 2017 | 14 | 9 |
| 2018 | 9 | 19 |
| 2019 | 4 | 10 |
| 2020 | 8 | 17 |
| 2021 | 9 | 16 |
| 2022 | 10 | 19 |
| 2023 | 13 | 26 |
| 2024 | 6 | 22 |
| 2025 | 6 | 14 |
| 2026 | 15 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nutritional composition comprising miR-312629 Sep 2026US 12,747,439 B2Societe des Produits Nestle S. A.
- Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation25 Aug 2026US 12,715,899 B2Seoul National University Hospital
- Melanogenesis detection method using FAM86A11 Aug 2026US 12,704,520 B2Research & Business Foundation Sungkyunkwan University
- Aptamer specifically binding to cancer stem cells, and use thereof7 Jul 2026US 12,674,167 B2HiCELL Tech
- Nucleic acid drug suppressing production of myostatin gene MRNA30 Jun 2026US 12,668,796 B2Knc Laboratories Co., Ltd.
- Synthetic mrna comprising apoptin protein coding sequence and use thereof20 Aug 2026US 2026/0242423 A1Knu-Industry Cooperation Foundation
- Composition containing nicotinamide mononucleotide13 Aug 2026US 2026/0232714 A1Meiji Holdings Co., Ltd.
- Water-Soluble Prolamin, Preparation Thereof, and Uses Thereof for Food-Grade Application Including Prolamin Compositions Combining Prolamin and DNA Taggants13 Aug 2026US 2026/0234605 A1SafeTraces, Inc.
- Nutritional Supplement Compositions and Methods for Enhancing Biological Functions6 Aug 2026US 2026/0223905 A1Best 365 Labs Inc.
- Polymorphic form of reduced beta-nicotinamide mononucleotide disodium salt, and preparation method therefor and use thereof25 Jun 2026US 2026/0176297 A1Effepharm (Shanghai) Co., Ltd.
Most cited
By later US patents
- High fat nutritional formula for infants and adults78US 5,709,888 AAbbott Laboratories · 1998
- Method for stimulation or repair and regeneration of intestinal gut cells in infants and enhancing the immune response of t-cells73US 4,994,442 AUnion Industrial y Agro-Ganadera, S. A. (UNIASA) · 1991
- Human desaturase gene and uses thereof73US 6,432,684 B1Abbott Laboratories · 2002
- Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products72US 5,985,339 A1999
- Infant nutritional formula with ribo-nucleotides64US 5,492,899 AAbbott Laboratories · 1996